SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : T/FIF Portfolio -- Ignore unavailable to you. Want to Upgrade?


To: WWS who wrote (891)5/19/1999 11:09:00 PM
From: Mike McFarland  Read Replies (1) | Respond to of 1073
 
Yeah, bit of a downer--except of course
for the last line of the article--(...20x
your money). So true, and I for one would
not be in the sector if it were not for
the thrill of potentially capturing the
elusive ten-bagger. Don't know if the nano-
caps are the best place to be, but at least
I know where my companies stand--do or die.

__
Here is today's SeattleTimes article from
BIO '99. It is a good example of how the popular
media continually serves up salty snacks instead
of real meat. A real shame that the Seattle Times,
with bio'99 right here this year, could not do better
than this today.

Article says nothing that was interesting at all to
me, and focuses on computers: Oh, naturally they
got Venter's Celery in there, better than chips,
but still just a light snack, so lame.
seattletimes.com

I was really disappointed when I turned to the Seattle Times
business section today, and here were the headlines:
Wash. Mutual buys California Mortgage firm
Gates touts Internet's potential
Labor problems color Alaska meeting
Life Sciences becoming dependent on computers



To: WWS who wrote (891)5/22/1999 4:35:00 PM
From: scaram(o)uche  Read Replies (2) | Respond to of 1073
 
Bill:

OK, I read the Eisinger article. Looks fairly balanced to me, even though it's very negative. However, it describes factors that drove the sector to this point. Yes, some companies will go out of business -- we've lost something like four in the last month. Goodbye. Nobody is going to miss a SHMN. Nobody.

Eisinger said "Things got bad because of countless unanticipated blow-ups". Unanticipated by whom? This is bull, but.... it is true that "expert" analysts have largely been rotten.

He said "And the strong performance and growth of big phamaceuticals means they need bigger acquisitions and bigger drugs to make a financial impact." True in spirit and in most of practice, irrational as hell. And there are plenty of "bigger drugs" among biotech pipes.

The contributors to this thread are obviously doing better than the so-called experts. Beware of people that paint the sector with a broad brush. If Saks is going to tell you to buy the big caps in biotech, what is he needed for? One can say "buy AMGN, BGEN, IMNX, GENZ and MEDI and goodbye Saks baby!"

Bunch of chicken sh*t dogma. I've been doing well in the lower tiers through the slaughter, and I'm going to do better in the coming months.

Hope everyone is having a great weekend!

Rick